SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SRT3 - DE0007165631
261.4 EUR
+8.9 (+3.52%)
Overall SRT3 gets a fundamental rating of 3 out of 10. We evaluated SRT3 against 20 industry peers in the Life Sciences Tools & Services industry. SRT3 may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SRT3 is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year SRT3 was profitable.
- In the past year SRT3 had a positive cash flow from operations.
- SRT3 had positive earnings in each of the past 5 years.
- SRT3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of SRT3 (1.39%) is worse than 85.00% of its industry peers.
- SRT3 has a worse Return On Equity (5.01%) than 75.00% of its industry peers.
- SRT3's Return On Invested Capital of 4.71% is on the low side compared to the rest of the industry. SRT3 is outperformed by 80.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for SRT3 is in line with the industry average of 9.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
- SRT3 has a worse Profit Margin (3.80%) than 85.00% of its industry peers.
- SRT3's Profit Margin has declined in the last couple of years.
- SRT3's Operating Margin of 14.06% is on the low side compared to the rest of the industry. SRT3 is outperformed by 75.00% of its industry peers.
- In the last couple of years the Operating Margin of SRT3 has declined.
- SRT3's Gross Margin of 46.48% is fine compared to the rest of the industry. SRT3 outperforms 70.00% of its industry peers.
- SRT3's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRT3 is destroying value.
- The number of shares outstanding for SRT3 has been increased compared to 1 year ago.
- SRT3 has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, SRT3 has an improved debt to assets ratio.
2.2 Solvency
- SRT3 has an Altman-Z score of 2.50. This is not the best score and indicates that SRT3 is in the grey zone with still only limited risk for bankruptcy at the moment.
- SRT3 has a worse Altman-Z score (2.50) than 60.00% of its industry peers.
- SRT3 has a debt to FCF ratio of 8.92. This is a slightly negative value and a sign of low solvency as SRT3 would need 8.92 years to pay back of all of its debts.
- The Debt to FCF ratio of SRT3 (8.92) is worse than 75.00% of its industry peers.
- A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT3 has dependencies on debt financing.
- SRT3's Debt to Equity ratio of 1.28 is on the low side compared to the rest of the industry. SRT3 is outperformed by 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.5 |
ROIC/WACC0.56
WACC8.43%
2.3 Liquidity
- A Current Ratio of 0.95 indicates that SRT3 may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.95, SRT3 is doing worse than 90.00% of the companies in the same industry.
- A Quick Ratio of 0.49 indicates that SRT3 may have some problems paying its short term obligations.
- The Quick ratio of SRT3 (0.49) is worse than 95.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 59.34% over the past year.
- Measured over the past years, SRT3 shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.87% on average per year.
- Looking at the last year, SRT3 shows a small growth in Revenue. The Revenue has grown by 5.82% in the last year.
- SRT3 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
- Based on estimates for the next years, SRT3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.87% on average per year.
- Based on estimates for the next years, SRT3 will show a quite strong growth in Revenue. The Revenue will grow by 8.45% on average per year.
EPS Next Y22.67%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
EPS Next 5Y18.87%
Revenue Next Year5.32%
Revenue Next 2Y6.73%
Revenue Next 3Y8.71%
Revenue Next 5Y8.45%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- SRT3 is valuated quite expensively with a Price/Earnings ratio of 57.32.
- Based on the Price/Earnings ratio, SRT3 is valued more expensive than 90.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.32, SRT3 is valued quite expensively.
- Based on the Price/Forward Earnings ratio of 43.25, the valuation of SRT3 can be described as expensive.
- SRT3's Price/Forward Earnings ratio is rather expensive when compared to the industry. SRT3 is more expensive than 90.00% of the companies in the same industry.
- SRT3 is valuated expensively when we compare the Price/Forward Earnings ratio to 24.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 57.32 | ||
| Fwd PE | 43.25 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRT3 is on the same level as its industry peers.
- 60.00% of the companies in the same industry are cheaper than SRT3, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.9 | ||
| EV/EBITDA | 24.6 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- SRT3's earnings are expected to grow with 22.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.53
PEG (5Y)N/A
EPS Next 2Y21.45%
EPS Next 3Y22.86%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.37%, SRT3 is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.54, SRT3 has a dividend in line with its industry peers.
- With a Dividend Yield of 0.37, SRT3 pays less dividend than the S&P500 average, which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
5.2 History
- The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- SRT3 pays out 37.92% of its income as dividend. This is a sustainable payout ratio.
- SRT3's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
FRA:SRT3 (1/22/2026, 5:36:15 PM)
261.4
+8.9 (+3.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-16 2025-10-16/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners4.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.57B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target387.02 (48.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.49%
PT rev (3m)22.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 57.32 | ||
| Fwd PE | 43.25 | ||
| P/S | 5.56 | ||
| P/FCF | 40.9 | ||
| P/OCF | 22.39 | ||
| P/B | 7.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.6 |
EPS(TTM)4.56
EY1.74%
EPS(NY)6.04
Fwd EY2.31%
FCF(TTM)6.39
FCFY2.45%
OCF(TTM)11.68
OCFY4.47%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)2.53
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.5 |
F-Score7
WACC8.43%
ROIC/WACC0.56
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.67%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
EPS Next 5Y18.87%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.32%
Revenue Next 2Y6.73%
Revenue Next 3Y8.71%
Revenue Next 5Y8.45%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year101.42%
EBIT Next 3Y38.38%
EBIT Next 5Y26.17%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
Can you provide the valuation status for SARTORIUS AG-VORZUG?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
What is the valuation of SARTORIUS AG-VORZUG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 57.32 and the Price/Book (PB) ratio is 7.34.
Can you provide the financial health for SRT3 stock?
The financial health rating of SARTORIUS AG-VORZUG (SRT3.DE) is 1 / 10.